แนวทางการกากับการใช้ยา Trastuzumab ข้อบ่งใช้มะเร็งเ

Trastuzumab is a monoclonal antibody targeted against the HER2 tyrosine kinase receptor The majority of patients with metastatic breast

Trastuzumab emtansine binds to the HER2 receptor's sub-domain IV and goes into the cell by receptor-mediated endocytosis Lysosomes degrade trastuzumab

trastuzumab The results of this trial indicate that trastuzumab is active as a single agent and produces durable objective responses in women with HER2-overexpressing

trastuzumab If you're having trastuzumab to treat primary breast cancer after surgery, it's usually given for 1 year Some people may be offered